- Home
- FTI vs ASND Comparison
FTI vs ASND Comparison
Compare FTI & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTI | ASND |
|---|---|---|
| Founded | 1884 | 2006 |
| Country | United Kingdom | Denmark |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6B | 13.6B |
| IPO Year | 2016 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FTI | ASND |
|---|---|---|
| Price | $65.05 | $236.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 15 |
| Target Price | $61.42 | ★ $278.80 |
| AVG Volume (30 Days) | ★ 4.0M | 815.1K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.31% | N/A |
| EPS Growth | ★ 20.42 | N/A |
| EPS | ★ 2.30 | N/A |
| Revenue | ★ $9,932,600,000.00 | N/A |
| Revenue This Year | $8.54 | $98.02 |
| Revenue Next Year | $5.39 | $43.13 |
| P/E Ratio | $28.25 | ★ N/A |
| Revenue Growth | ★ 9.35 | N/A |
| 52 Week Low | $22.12 | $124.06 |
| 52 Week High | $68.29 | $248.60 |
Technical Indicators
Market Signals| Indicator | FTI | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 67.35 | 57.11 |
| Support Level | $58.67 | $190.49 |
| Resistance Level | N/A | $242.00 |
| Average True Range (ATR) | 2.20 | 9.85 |
| MACD | -0.21 | 0.91 |
| Stochastic Oscillator | 68.19 | 65.11 |
Price Performance
Historical ComparisonAbout FTI TechnipFMC plc
TechnipFMC is the largest provider of offshore oilfield services, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea construction services. The company also provides various pieces of surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of Technip and FMC Technologies.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.